Obstructive sleep apnoea is a common condition that has been shown to impact cardiovascular and other health and quality of life outcomes. What have we learned from the recently published SAVE study – the largest intervention study in obstructive sleep apnoea?
- Obstructive sleep apnoea (OSA) is a common condition that can significantly impact health, accident risk and quality of life.
- OSA is associated with increased cardiovascular risk.
- In people with significant OSA and existing cardiovascular or cerebrovascular disease, treatment with continuous positive airway pressure (CPAP) does not appear to reduce the risk of future cardiovascular events.
- Treatment should be individualised according to symptoms, comorbidities and patient factors such as fatigue-critical occupation.
Picture credit: © BSIP/Diomedia.com
Model used for illustrative puroses only